Products for Research Use Only
RegisterLogin

D- (RYTVELA)

CAT: 0804-HY-P10353Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10353Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
D- (RYTVELA) is a specific inhibitor of human thymocyte proliferation with an IC50 of 1 nM. d- (RYTVELA) inhibits IL-1–induced signaling pathways[1].
CAS Number
868844-53-5
UNSPSC
12352209
Target
Interleukin Related
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/d-rytvela.html
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1C[C@@H](NC([C@H](N)CCCNC(N)=N)=O)C(N[C@H]([C@@H](O)C)C(N[C@H](C(C)C)C(N[C@H](CCC(O)=O)C(N[C@H](CC(C)C)C(N[C@H](C)C(O)=O)=O)=O)=O)=O)=O
Molecular Formula
C38H62N10O12
Molecular Weight
850.96
References & Citations
[1]Tiffany Habelrih, et al. Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes. Am J Obstet Gynecol. 2023, 228, 4.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P10474-01RYTVELA
HY-N9914S-01D-Psicose-d
HY-N0379S11-01D-Mannose-d
HY-W018772S6-01D-Ribose-d
HY-128753S6-01D-Lyxose-d
HY-N7092S8-01D-Fructose-d
HY-P4549H-D-Ala-D-Ala-D-Ala-D-Ala-OH
HY-P3881(D-Arg1, D-Pro2, D-Phe7, D-His9) -Substance P
HY-W018772S7-01D-Ribose-d-1
HY-W415917D-Glycero-D-mannoheptose

Alternative Products

CatalogName
GTR18894455Rytvela
T83745RYTVELA TFA
GTR19063073-01D- (RYTVELA)
GTR18917850Rytvela scrambled peptide
PP47364-01H-rytvela-OH

Popular Products